*WHO REFUSES TO NAME MEMBERS OF KEY EMERGENCY COMMITTEE: PACKED WITH BIG PHARMA LOBBYISTS AS IN 2009?
*WHO EBOLA EXPERT CONSULTANT HAS LINKS TO NOVARTIS VACCINE MANUFACTURER
*BIG PHARMA SET TO EARN A FORTUNE FROM EBOLA VACCINES, SAYS HANDELSZEITUNG
*WHO SAYS NO EPIDEMIC AS UK PUTS HOSPITALS ON ALERT OVER EBOLA
*NEW GUIDELINES SEEM TO ALLOW FOR PANDEMIC PLANS TO BE USED FOR EPIDEMIC TOO AND FOR INDEPENDENT ACTION BY NATIONS
*READ SCANDALOUS WHO ANSWERS IN EMAIL EXCHANGE
The secrecy of WHO surrounding the new Ebola epidemic was underlined when WHO spokesperson Gregory Härtl refused to reveal the names of the people who sit on WHO’s new key Emergency Committee, sparking concerns that the UN health body is once more concealing pharmaceutical conflicts of interests.
In an astonishing email exchange on Friday, Hartl not only refused to reveal the names of key advisors; he also refused to answer simple, factual questions about the Ebola epidemic unfolding in Guinea.
He even denied there were any plans to declare an epidemic – and trigger “contractual agreements” presumably for pandemic vaccines under new more elastic “interim” guidelines which apply to pandemics and epidemics. This, in spite of the media hype about Ebola’s rapid spread and danger, the French government putting a plane under quarantine and the UK government putting hospitals on alert.
Read my email exchange with Hartl on Thursday and Friday at the end of this report.
Crucially, these vaccine contracts now seem to be able to be triggered by individual nations such as France under the new WHO interim guidelines – and no longerjust by WHO as in 2009. Read the rest of this entry »